about
An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.In vitro and in vivo studies of the trypanocidal activity of four terpenoid derivatives against Trypanosoma cruziLibrary of Seleno-Compounds as Novel Agents against Leishmania Species.Effective anti-leishmanial activity of minimalist squaramide-based compounds.In vitro leishmanicidal activity of pyrazole-containing polyamine macrocycles which inhibit the Fe-SOD enzyme of Leishmania infantum and Leishmania braziliensis species.In vitro antileishmanial activity and iron superoxide dismutase inhibition of arylamine Mannich base derivatives.In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives.In vitro anti-leishmania evaluation of nickel complexes with a triazolopyrimidine derivative against Leishmania infantum and Leishmania braziliensis.Epidemiology of American trypanosomiasis in northern Peru.An iron-superoxide dismutase antigen-based serological screening of dogs indicates their potential role in the transmission of cutaneous leishmaniasis and trypanosomiasis in Yucatan, Mexico.More productive in vitro culture of Cryptosporidium parvum for better study of the intra- and extracellular phases.Simple dialkyl pyrazole-3,5-dicarboxylates show in vitro and in vivo activity against disease-causing trypanosomatids.Synthesis and evaluation of in vitro and in vivo trypanocidal properties of a new imidazole-containing nitrophthalazine derivative.Phytomonas iron superoxide dismutase: a possible molecular marker.Diagnosis of Congenital Chagas Disease Using an Iron Superoxide Dismutase Excreted as Antigen, in Mothers and Their Children During the First Year of Life.In vitro leishmanicidal activity of 1,3-disubstituted 5-nitroindazoles.Imidazole-containing phthalazine derivatives inhibit Fe-SOD performance in Leishmania species and are active in vitro against visceral and mucosal leishmaniasis.Activity of Pt(II) and Ru(III) Triazolopyrimidine Complexes Against Parasites of the Genus Leishmania, Trypanosomas and Phytomonas.Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis.In vitro evaluation of new terpenoid derivatives against Leishmania infantum and Leishmania braziliensis.Activities of Pt(II) and Ru(III) triazole-pyrimidine complexes against Trypanosoma cruzi and T. brucei brucei.Copper (II) complexes of [1,2,4]triazolo [1,5-a]pyrimidine derivatives as potential anti-parasitic agents.Leishmania infantum secreted iron superoxide dismutase purification and its application to the diagnosis of canine Leishmaniasis.Cytotoxicity of three new triazolo-pyrimidine derivatives against the plant trypanosomatid: Phytomonas sp. isolated from Euphorbia characias.Imidazole-containing phthalazine derivatives inhibit Fe-SOD performance in Leishmania species and are active in vitro against visceral and mucosal leishmaniasis--CORRIGENDUM.Specific primers design based on the superoxide dismutase b gene for Trypanosoma cruzi as a screening tool: Validation method using strains from Colombia classified according to their discrete typing unit.Diterpenoid alkaloid derivatives as potential chemotherapeutic agents in American trypanosomiasis.Excreted Leishmania peruviana and Leishmania amazonensis iron-superoxide dismutase purification: specific antibody detection in Colombian patients with cutaneous leishmaniasis.Herpetomonas spp. isolated from tomato fruits (Lycopersicon esculentum) in southern Spain.Phytomonas spp: superoxide dismutase in plant trypanosomes.Scorpiand-like azamacrocycles prevent the chronic establishment of Trypanosoma cruzi in a murine model.In vitro activity of scorpiand-like azamacrocycle derivatives in promastigotes and intracellular amastigotes of Leishmania infantum and Leishmania braziliensis.Identification of New World Leishmania species from Peru by biochemical techniques and multiplex PCR assay.Purification of a Fe-SOD excreted by Leishmania braziliensis for specific antibodies detection in Mexican human sera: Cutting-edge the knowledge.In vivo trypanosomicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against acute and chronic phases of Chagas diseaseSynthesis and Biological in vitro and in vivo Evaluation of 2-(5-Nitroindazol-1-yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas DiseaseTetradentate polyamines as efficient metallodrugs for Chagas disease treatment in murine modelNew perspectives on the synthesis and antichagasic activity of 3-alkoxy-1-alkyl-5-nitroindazolesAnti-Trypanosoma cruzi antibody detection in eastern Andalusia (Spain)Synthesis and biological evaluation of N,N'-squaramides with high in vivo efficacy and low toxicity: toward a low-cost drug against Chagas disease
P50
Q35849652-883A3C39-3004-4AAD-B846-0FB579EFF85AQ36213275-D2AF98C1-62B9-4AEF-A594-34B01CD9A5EEQ36315604-28BD1F31-C603-4341-9672-8D51EBE452B9Q38736570-924ACD3E-17D7-4912-8E2F-CE1FC6A4B3B8Q39014739-F2C2DABF-4819-4D39-8D04-E57FDE7A2079Q39219186-FCC43B30-162D-45EE-9752-D179071F32DAQ39268283-DDC9E163-98DA-4938-BD91-D162800CA61EQ39357153-492EE35F-ACB3-4C2D-96CE-64E871DF293BQ39554247-3B0538B3-CA64-4699-8E32-1A8489404352Q39971200-72674FAE-3E91-405F-93C7-068BBA48BE68Q40091208-D67C5A6D-D83E-4DA4-8B78-9A3770286007Q40268471-C345513B-5A30-4F03-A111-E42CDC6753FAQ40367850-8CACF927-7DD5-4E9E-A5B6-9EC01B22F51BQ40514844-9EE74DEC-8E27-4F42-B2BB-5FC68D57BDF4Q40710345-0EDE6ECA-E38A-4D5C-BC68-EE9F73FBD9E3Q41247153-7FA30B76-F158-4EAB-831E-9EC82CC1E6DEQ41370122-1CCE212E-8209-431C-A56B-EAA5C9D68A8EQ42120039-B540063A-340C-4D98-BEF5-9354B5EC2947Q42201724-A5125E30-46FE-458E-B174-D220623B49F0Q44027652-95E1218B-1FF6-41CC-B30E-E2E4D0B4CF82Q44699237-746A7268-E9A2-4F35-80E4-81181EA816FFQ44718637-53F6252A-684C-4AC2-B8F9-7FDDC75316BFQ44767523-8544B024-2411-45E1-A97D-BBC47703C34EQ45159159-6DF9EC3D-9338-4DF0-AD9B-46AB0DDD6DD1Q46717898-5D9C8FEB-2150-4A6C-BBB3-5EEB3666C523Q46808018-D9C670D0-1950-4FB2-A941-689C169AF102Q46878212-300BE20A-58AA-4074-966F-18667CCE6D42Q46944556-3207EA38-F3DC-4A37-84EA-D69BC517317AQ48081913-67821BAF-589E-4268-AFA3-C9EA3BD91420Q52588538-A3D3E7B5-D219-40EC-AC3D-84C8CDAC2ECDQ54301687-FE86D7E7-4C51-4012-9709-73647D9ABEFDQ54317494-A1737652-565C-45F3-84A3-92750B76C3E6Q54561677-F0614471-7D01-4485-8871-16D876516A29Q55476104-6172B171-1110-45EA-A43B-3462176CECDCQ57185289-3F9D38D7-3D26-4176-9B56-F6C4FD626DEAQ57293858-AB0967F9-FD3E-4A1D-B3DB-00D23DBC88F3Q58842354-F7A7A685-305C-460C-95EF-AD3464494AD9Q58843112-92EE1660-2377-46E2-905A-3129032DBE00Q58843144-FBFE1A3C-2288-4952-A535-5A71411BD0F6Q58843153-90021290-68B9-4B18-A3ED-6B1FA10663BD
P50
description
researcher ORCID ID=0000-0002-4316-2742
@en
wetenschapper
@nl
name
C Marín
@en
C Marín
@nl
type
label
C Marín
@en
C Marín
@nl
prefLabel
C Marín
@en
C Marín
@nl
P106
P31
P496
0000-0002-4316-2742